• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性肾脏病中的软组织钙化——血管系统之外

Soft tissue calcifications in chronic kidney disease-beyond the vasculature.

作者信息

Fajol Abul, Faul Christian

机构信息

Section of Mineral Metabolism, Division of Nephrology, Department of Medicine, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA.

出版信息

Pflugers Arch. 2025 Jun 5. doi: 10.1007/s00424-025-03098-0.

DOI:10.1007/s00424-025-03098-0
PMID:40471241
Abstract

Inappropriate mineralization of soft tissues, also called ectopic calcification, is a well-known pathology in chronic kidney disease (CKD) that is associated with increases in systemic phosphate levels. Vascular calcification is a major contributor to cardiovascular injury and high mortality rates in CKD patients. Therefore, most animal and human studies have focused on the vasculature when describing ectopic calcifications and on the pathologic actions of elevated phosphate on vascular smooth muscle cells in this process. The extent of calcifications within soft tissues beyond the vasculature is not well described, and the involvement of cell types other than vascular smooth muscle cells is not clear. Here we provide a summary of CKD-associated extravascular calcifications in various tissues, which includes the lung, the gastrointestinal system, the liver, the skin, and the brain. Since phosphate elevations and widespread ectopic calcifications do not only occur in the context of CKD, but also in rare genetic disorders that affect the regulators of phosphate metabolism, the cellular transporters of phosphate and the factors protecting from mineral depositions outside of bone, we also discuss these pathologic scenarios. We describe different types of ectopic calcification to flesh out common aspects as well as differences in the potential mechanisms and target cell types. We postulate that phosphate elevations might act in various ways and on various tissues, which together causes a wide spectrum of phosphate-induced pathologies in CKD.

摘要

软组织的异常矿化,也称为异位钙化,是慢性肾脏病(CKD)中一种众所周知的病理现象,与全身磷酸盐水平升高有关。血管钙化是CKD患者心血管损伤和高死亡率的主要原因。因此,大多数动物和人体研究在描述异位钙化时都集中在脉管系统,以及在此过程中磷酸盐升高对血管平滑肌细胞的病理作用。脉管系统以外软组织内的钙化程度描述得并不充分,除血管平滑肌细胞外其他细胞类型的参与情况也不清楚。在这里,我们总结了CKD相关的各种组织中的血管外钙化,包括肺、胃肠道系统、肝脏、皮肤和大脑。由于磷酸盐升高和广泛的异位钙化不仅发生在CKD的情况下,也发生在影响磷酸盐代谢调节因子、磷酸盐细胞转运体以及防止骨外矿物质沉积的因子的罕见遗传疾病中,我们也讨论了这些病理情况。我们描述了不同类型的异位钙化,以阐明潜在机制和靶细胞类型的共同方面以及差异。我们推测,磷酸盐升高可能以多种方式作用于各种组织,共同导致CKD中一系列由磷酸盐引起的病理状况。

相似文献

1
Soft tissue calcifications in chronic kidney disease-beyond the vasculature.慢性肾脏病中的软组织钙化——血管系统之外
Pflugers Arch. 2025 Jun 5. doi: 10.1007/s00424-025-03098-0.
2
The Pathologic Actions of Phosphate in CKD.慢性肾脏病中磷酸盐的病理作用
Kidney360. 2025 Apr 17;6(6):1040-1049. doi: 10.34067/KID.0000000820.
3
Structural and molecular imaging-based characterization of soft tissue and vascular calcification in hyperphosphatemic familial tumoral calcinosis.基于结构和分子影像学的高磷血症家族性肿瘤性钙化症软组织和血管钙化的特征描述。
J Bone Miner Res. 2024 Sep 2;39(9):1327-1339. doi: 10.1093/jbmr/zjae115.
4
Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD).用于预防和治疗慢性肾脏病-矿物质和骨异常(CKD-MBD)的磷结合剂。
Cochrane Database Syst Rev. 2025 Jun 27;6(6):CD006023. doi: 10.1002/14651858.CD006023.pub4.
5
Chronic Kidney Disease-associated Lung Injury Is Mediated by Phosphate-induced MAPK/AKT Signaling.慢性肾脏病相关肺损伤是由磷酸盐诱导的 MAPK/AKT 信号通路介导的。
Am J Respir Cell Mol Biol. 2024 Dec;71(6):659-676. doi: 10.1165/rcmb.2024-0008OC.
6
Elevated phosphate levels in CKD - a direct threat for the heart.慢性肾脏病中升高的磷酸盐水平——对心脏的直接威胁。
Nephrol Dial Transplant. 2025 Jun 30;40(7):1294-1309. doi: 10.1093/ndt/gfaf001.
7
Soluble αKlotho interacts with Hsp90aa1 to inhibit the chaperone machinery-mediated Hif1α stabilization and alleviate CKD-induced vascular calcification.可溶性α-klotho与热休克蛋白90α家族成员1(Hsp90aa1)相互作用,抑制伴侣蛋白机制介导的低氧诱导因子1α(Hif1α)稳定,并减轻慢性肾脏病(CKD)诱导的血管钙化。
J Mol Cell Cardiol. 2025 Aug;205:100-116. doi: 10.1016/j.yjmcc.2025.07.003. Epub 2025 Jul 5.
8
Sexual Harassment and Prevention Training性骚扰与预防培训
9
Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD).用于预防和治疗慢性肾脏病-矿物质和骨异常(CKD-MBD)的磷结合剂。
Cochrane Database Syst Rev. 2018 Aug 22;8(8):CD006023. doi: 10.1002/14651858.CD006023.pub3.
10
Design considerations for future renoprotection trials in the era of multiple therapies for chronic kidney disease.慢性肾脏病多种治疗时代未来肾脏保护试验的设计考量
Nephrol Dial Transplant. 2025 Feb 5;40(Supplement_1):i70-i79. doi: 10.1093/ndt/gfae210.

本文引用的文献

1
Changes in local mineral homeostasis facilitate the formation of benign and malignant testicular microcalcifications.局部矿物质稳态的变化促进良性和恶性睾丸微钙化的形成。
Elife. 2025 Apr 25;13:RP95545. doi: 10.7554/eLife.95545.
2
The formation and function of calciprotein particles.钙蛋白颗粒的形成与功能。
Pflugers Arch. 2025 Jun;477(6):753-772. doi: 10.1007/s00424-025-03083-7. Epub 2025 Apr 23.
3
The Pathologic Actions of Phosphate in CKD.慢性肾脏病中磷酸盐的病理作用
Kidney360. 2025 Apr 17;6(6):1040-1049. doi: 10.34067/KID.0000000820.
4
Vascular Calcification and CKD: Challenges, Emerging Targets, and Future Perspectives.血管钙化与慢性肾脏病:挑战、新出现的靶点及未来展望
Clin J Am Soc Nephrol. 2025 Apr 16. doi: 10.2215/CJN.0000000733.
5
Vascular calcification inhibitors in chronic kidney disease.慢性肾脏病中的血管钙化抑制剂
Clin Chim Acta. 2025 May 15;572:120271. doi: 10.1016/j.cca.2025.120271. Epub 2025 Apr 2.
6
The role of osteopontin in chronic kidney disease-mineral bone disorder.骨桥蛋白在慢性肾脏病-矿物质和骨异常中的作用。
Curr Opin Nephrol Hypertens. 2025 Jul 1;34(4):291-296. doi: 10.1097/MNH.0000000000001074. Epub 2025 Apr 1.
7
Efficacy and Safety of Phosphate-Lowering Agents for Adult Patients with CKD Requiring Dialysis: A Network Meta-Analysis.降磷药物对需要透析的成年慢性肾脏病患者的疗效和安全性:一项网状Meta分析
Clin J Am Soc Nephrol. 2025 May 1;20(5):676-696. doi: 10.2215/CJN.0000000665. Epub 2025 Mar 14.
8
Elevated phosphate levels in CKD - a direct threat for the heart.慢性肾脏病中升高的磷酸盐水平——对心脏的直接威胁。
Nephrol Dial Transplant. 2025 Jun 30;40(7):1294-1309. doi: 10.1093/ndt/gfaf001.
9
Controlled dietary phosphate loading in healthy young men elevates plasma phosphate and FGF23 levels.对健康年轻男性进行饮食中磷酸盐的控制性负荷会提高血浆磷酸盐和FGF23水平。
Pflugers Arch. 2025 Mar;477(3):495-508. doi: 10.1007/s00424-024-03046-4. Epub 2024 Nov 27.
10
Gastrointestinal calciphylaxis: a rare and devastating complication in end-stage kidney disease.胃肠道钙化防御:终末期肾病中一种罕见且严重的并发症。
CEN Case Rep. 2025 Apr;14(2):297-300. doi: 10.1007/s13730-024-00944-5. Epub 2024 Nov 14.